Last update 02 May 2024
KOREA UNITED PHARM, Inc.

KOREA UNITED PHARM, Inc.

Public Company|
1987|
South Korea
|
500-1,000
| KRX: 033270|

Overview

Basic Info

Introduction
Founded in 1987, Korea United Pharm. Inc. has grown into a multinational pharmaceutical corporation with the mission of being a Korean-owned entity. Through significant investments in research and development, extensive expertise, and top researchers, the company has successfully launched numerous pharmaceutical drugs such as Cilostan CR Tab, Gastiin CR Tab, and Clanza CR Tab. As a result, they have established themselves as a major competitor in the pharmaceutical industry and have been recognized by Forbes magazine as one of Asia's 200 most promising companies.

Tags

Endocrinology and Metabolic Disease
Respiratory Diseases
Immune System Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Top 5 Drug TypeCount
Small molecule drug24
Unknown18

Corporation Tree

Boost your research with our corporation tree data.
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 03 Jul 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
19
7
Preclinical
Phase 1 Clinical
7
1
Phase 2 Clinical
Phase 3 Clinical
7
1
NDA/BLA
Other
8
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
UI-044
Lipid Metabolism Disorders
More
NDA/BLA
UI018
( Lipid )
Vascular Diseases
More
Phase 3
UI-022/UI-023
Vascular Diseases
More
Phase 3
UI-063
Inflammation
More
Phase 3
UI-023
Platelet Aggregation, Spontaneous
More
Phase 3
Login to view more data

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
Unearth financing trends to validate and advance investment opportunities.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free